![Paul B. Knight](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul B. Knight has been a Director of Molecular Diagnostics & Therapeutics, Inc. since August 2000.
He is President of Transwestern Financial Advisors.
Mr. Knight has experience in capital management, financial forecasting, preparation of financial statements, and overseeing SEC filings and requirements
| Empresas | Cargo | Inicio |
|---|---|---|
Molecular Diagnostics & Therapeutics, Inc.
 Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes nuclear medicines | Director/Miembro de la Junta | 01/08/2000 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
Molecular Diagnostics & Therapeutics, Inc.
Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes nuclear medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
